Fundz

Orcosa reported raising $7.28 Million in an initial SEC Form D filing, from an offering of $15.5 Million

PRIVATEJan 07, 2025

Amount Raised

$7.28 Million

$7.28 Million sold, per SEC Form D (first sale Dec 23, 2024)

Round Type

Venture

EwingBiotechnology

Who to call at Orcosa, and when

A new round usually means Orcosa is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Orcosa raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Orcosa, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Orcosa. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Orcosa

Location

7 GRAPHICS DRIVE

Ewing, Illinois, United States

About

Orcosa's mission is to improve patient outcomes through our next generation therapeutic delivery system, the Rapid Infusion Technology (RITe™) Platform, a fast acting, easy-to-take tablet engineered to enhance drug absorption. With our proprietary manufacturing processes and state of the art cGMP-compliant facility in the U.S., we have developed our first product candidate, ORAVEXX™, a non-addictive proprietary cannabidiol composition that utilizes the RITe™ Platform to treat pain and provide a safe, alternative treatment option to opioids. We are empowering the medical community by partnering with leading research institutions and physicians to support multiple FDA-authorized investigator-initiated clinical trials that utilize the RITe™ Platform to determine the safety and efficacy of CBD for the management of pain and inflammation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Orcosa raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts6 people are listed at Orcosa. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Orcosa's next move

See what Strategic adds

Orcosa raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.